Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of tgAAC09 HIV Vaccine in Healthy Volunteers
NCT00888446Phase 2Completed
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Oct 2005
- Primary completion
- Dec 2007
- Modality
- Viral Vector Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of tgAAC09 in human immunodeficiency virus infection (HIV), sponsored by International AIDS Vaccine Initiative. Started Oct 2005; status: completed.
02
Drugs
tgAAC09
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00888446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888446.